Mills Charles N.

SEC Form 4 insider trading activity

Mills Charles N. has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 22, 2025.

On the most recent filing, Mills Charles N. is listed as Director at Medline Inc. Inside the rolling window, Mills Charles N. reported 1 open-market purchase totaling $74.8M in MDLN and no open-market sales.

Companies traded

Other insiders at MDLN

Insider Buying

$74.8M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MDLNPurchase$74.8MDec 22SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Mills Charles N. made?

Mills Charles N. has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2025.

Which companies does Mills Charles N. trade?

Mills Charles N. has filed SEC Form 4 disclosures for 1 company, including MDLN.

When was Mills Charles N.'s most recent SEC Form 4 filing?

Mills Charles N.'s most recent SEC Form 4 filing on Tracefour is dated Dec 22, 2025.

What is Mills Charles N.'s total buy and sell value in the current window?

Inside the rolling retention window, Mills Charles N. bought $74.8M and sold $0 based on SEC Form 4 filings.

What was Mills Charles N.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 2,579,310 MDLN shares on 2025-12-18, worth $74.8M, per SEC Form 4 filings.